Gulen Tonga

Tessera Therapeutics

BIOGRAPHY

Gulen Tonga is the principal scientist at Tessera Therapeutics, where she supports the development of gene therapies for rare genetic liver diseases using the company’s Gene Writing technology. She focuses on lipid nanoparticle design to enable efficient RNA delivery to targeted organs and tissues, aiming to treat genetic disorders at their source.

Gulen brings deep expertise in advanced drug delivery systems and plays a key role in driving therapeutic innovation that bridges cutting-edge science with real-world impact in genetic medicine.